Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Thursday, June 30, 2022.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2022 (2022-06-30): -571.93%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-364.15%
RETURN ON EQUITY (ROE) AVG 3Y
-168.58%
RETURN ON EQUITY (ROE) AVG 5Y
-222.34%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
BeyondSpring Inc.
Market Cap
$30.34M
Return on Equity (ROE)
N/A
TTM Avg
-364.15%
3Y Avg
-168.58%
5Y Avg
-222.34%
Market Cap
$30.42M
Return on Equity (ROE)
-116.14%
TTM Avg
-228.74%
3Y Avg
113.10%
5Y Avg
76.03%
Market Cap
$30.59M
Return on Equity (ROE)
N/A
TTM Avg
10.32%
3Y Avg
-262.53%
5Y Avg
-267.00%
Market Cap
$29.91M
Return on Equity (ROE)
-132.18%
TTM Avg
-94.77%
3Y Avg
-38.62%
5Y Avg
-46.78%
Market Cap
$30.66M
Return on Equity (ROE)
-111.81%
TTM Avg
-29.10%
3Y Avg
-257.52%
5Y Avg
159.26%
Market Cap
$30.97M
Return on Equity (ROE)
-15.29%
TTM Avg
-28.05%
3Y Avg
-476.74%
5Y Avg
-371.52%
Market Cap
$29.58M
Return on Equity (ROE)
-120.40%
TTM Avg
-43.89%
3Y Avg
-83.08%
5Y Avg
-65.54%
Market Cap
$29.48M
Return on Equity (ROE)
-117.69%
TTM Avg
-1443.79%
3Y Avg
-971.02%
5Y Avg
-813.57%
Market Cap
$29.44M
Return on Equity (ROE)
N/A
TTM Avg
78.98%
3Y Avg
134.04%
5Y Avg
114.40%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BeyondSpring Inc. (BYSI) | $30.34M | N/A | -364.15% | -168.58% | -222.34% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.42M | -116.14% | -228.74% | 113.10% | 76.03% |
| MDxHealth S.A. (MDXH)vs › | $30.59M | N/A | 10.32% | -262.53% | -267.00% |
| CervoMed Inc. (CRVO)vs › | $29.91M | -132.18% | -94.77% | -38.62% | -46.78% |
| GridAI Technologies Corp. (GRDX)vs › | $30.66M | -111.81% | -29.10% | -257.52% | 159.26% |
| SCYNEXIS, Inc. (SCYX)vs › | $30.97M | -15.29% | -28.05% | -476.74% | -371.52% |
| Context Therapeutics Inc. (CNTX)vs › | $29.58M | -120.40% | -43.89% | -83.08% | -65.54% |
| Quantum Cyber N.V. (QUCY)vs › | $29.48M | -117.69% | -1443.79% | -971.02% | -813.57% |
| OneMedNet Corporation (ONMD)vs › | $29.44M | N/A | 78.98% | 134.04% | 114.40% |
| Nortech Systems Incorporated (NSYS)vs › | $31.77M | 2.91% | -2.27% | 5.52% | 6.87% |
ROE
N/A
ROA
-45.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2022-06-30 | -571.93% |
| 2022-03-31 | -696.05% |
| 2021-12-31 | -240.51% |
| 2021-09-30 | -188.52% |
| 2021-06-30 | -123.73% |
| 2021-03-31 | -85.34% |
| 2020-12-31 | -69.02% |
| 2020-09-30 | -238.94% |
| 2020-06-30 | -162.67% |
| 2020-03-31 | -265.02% |
| 2019-12-31 | -125.79% |
| 2019-09-30 | -186.22% |
| 2018-09-30 | -962.26% |
| 2018-06-30 | -286.07% |
| 2018-03-31 | -331.12% |
| 2017-12-31 | -338.91% |
| 2017-09-30 | -203.92% |
| 2017-06-30 | -139.79% |
| 2017-03-31 | -106.22% |
| 2016-12-31 | -98.84% |
| 2016-09-30 | -66.77% |
| 2016-06-30 | -254.21% |
| 2016-03-31 | -79.02% |
| 2015-12-31 | -89.05% |
